You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ocrelizumab

Showing 26 - 50 of 53
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Worldwide (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Ocrelizumab
  • Fort Collins, Colorado
  • +27 more
Aug 24, 2022

Cladribine Therapy After Anti CD20 Therapy

Active, not recruiting
  • Multiple Sclerosis
  • Cladribine Oral Tablet
  • +2 more
  • Lugano, Ticino, Switzerland
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugan
Mar 22, 2022

Upper Extremity Function in Multiple Sclerosis Advanced

Active, not recruiting
  • Multiple Sclerosis
  • +7 more
  • Ocrelizumab
  • Tampa, Florida
    Carol and Frank Morsani Center for Advanced Healthcare
Nov 2, 2022

Relapsing-Remitting Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Ocrelizumab Placebo, Fingolimod)

Recruiting
  • Relapsing-Remitting Multiple Sclerosis
  • Ocrelizumab
  • +3 more
  • La Jolla, California
  • +66 more
Jan 27, 2023

Rheumatoid Arthritis Trial (Methotrexate, Ocrelizumab, Placebo)

Terminated
Has Results
  • Rheumatoid Arthritis
  • (no location specified)
Nov 10, 2020

Lupus Nephritis, Systemic Lupus Erythematosus Trial (Corticosteroids, Cyclophosphamide, Mycophenolate Mofetil)

Terminated
Has Results
  • Lupus Nephritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Nov 27, 2020

Rheumatoid Arthritis Trial in South San Francisco (Methotrexate, ocrelizumab, Placebo)

Terminated
Has Results
  • Rheumatoid Arthritis
  • South San Francisco, California
    Trial Information Support Line
Nov 5, 2020

Rheumatoid Arthritis Trial (Methotrexate, Ocrelizumab, Placebo)

Terminated
Has Results
  • Rheumatoid Arthritis
  • (no location specified)
Oct 11, 2020

Relapsing Multiple Sclerosis Trial in Atlanta (Ocrelizumab, Platform)

Recruiting
  • Relapsing Multiple Sclerosis
  • Atlanta, Georgia
  • +1 more
Sep 14, 2021

Systemic Lupus Erythematosus Trial (Prednisone, Immunosuppressive regime (azathioprine, mycophenolate mofetil or methotrexate),

Terminated
Has Results
  • Systemic Lupus Erythematosus
  • (no location specified)
Aug 27, 2020

Relapsing Multiple Sclerosis Trial in Worldwide (Interferon beta-1a, Ocrelizumab-matching , Ocrelizumab)

Active, not recruiting
Has Results
  • Relapsing Multiple Sclerosis
  • Interferon beta-1a
  • +3 more
  • Phoenix, Arizona
  • +140 more
Jan 2, 2023

Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

Recruiting
  • Multiple Sclerosis
  • Ocrelizumab
  • +2 more
  • Cullman, Alabama
  • +202 more
Jan 27, 2023

Multiple Sclerosis Trial in Worldwide (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • Ocrelizumab
  • Buenos Aires, Argentina
  • +161 more
Aug 2, 2022

Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

Recruiting
  • Multiple Sclerosis
  • Ocrelizumab
  • +2 more
  • Homewood, Alabama
  • +211 more
Jan 13, 2023

Progressive Multiple Sclerosis (PMS) Trial in Worldwide (Ocrelizumab)

Active, not recruiting
  • Progressive Multiple Sclerosis (PMS)
  • Ocrelizumab
  • Laguna Hills, California
  • +125 more
Jan 13, 2023

Multiple Sclerosis, Relapse, Primary Progressive Multiple Sclerosis Trial in Paris (Ocrelizumab)

Recruiting
  • Multiple Sclerosis
  • +2 more
  • Ocrelizumab
  • Paris, France
    Hôpital Saint-Antoine - Service de Neurologie
Jan 27, 2020

Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Placebo)

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Ocrelizumab
  • Placebo
  • Scottsdale, Arizona
  • +197 more
Jan 2, 2023

Ocrelizumab in Relapsing or Primary Progressive Multiple

Active, not recruiting
  • Multiple Sclerosis
  • Ocrelizumab
  • Amstetten, Austria
  • +164 more
Aug 22, 2022

Multiple Sclerosis, Primary Progressive Trial in Worldwide (fenebrutinib, ocrelizumab, )

Recruiting
  • Multiple Sclerosis, Primary Progressive
  • Homewood, Alabama
  • +211 more
Jan 5, 2023

Rheumatoid Arthritis Trial in United States (Infliximab, Methotrexate, Methylprednisolone)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +52 more
Oct 13, 2020

Real-world Data of Ocrelizumab in Multiple Sclerosis in LATAM

Unknown status
  • Multiple Sclerosis
  • Ocrelizumab
  • Buenos Aires, Argentina
  • +3 more
Aug 7, 2019

Multiple Sclerosis, Relapsing-Remitting Trial in Canada, United States (Ocrelizumab)

Completed
Has Results
  • Multiple Sclerosis, Relapsing-Remitting
  • Ocrelizumab
  • Cullman, Alabama
  • +81 more
May 8, 2020

Rheumatoid Arthritis Trial in Worldwide (Leflunomide, Methotrexate, Ocrelizumab)

Terminated
Has Results
  • Rheumatoid Arthritis
  • Anniston, Alabama
  • +265 more
Aug 8, 2019

Mechanism of Action of Ocrelizumab in Multiple Sclerosis

Unknown status
  • Multiple Sclerosis
  • Immune System Diseases
  • ocrelizumab
  • Chicago, Illinois
    University of Chicago
Nov 14, 2017

Multiple Sclerosis Trial in United States (Ocrelizumab)

No longer available
  • Multiple Sclerosis
  • Ocrelizumab
  • Phoenix, Arizona
  • +55 more
Sep 4, 2017